Diversity & inclusion must go beyond superficial gestures to the heart of institutions, say African Business leaders at ASP Summit 2025
The fourth annual Africa Soft Power Summit took place in Nairobi, Kenya from May 21st – 25th, bringing together public and private sector leaders from across the worlds of finance, technology, creativity and more. Themed 'Africa's Growth Engine: Aligning the Flow of Money, Innovation, and Global Opportunities', the summit centred around two main conferences:
At the former, key participants made their thoughts clear on the importance of diversity, equity and inclusion (DEI), with a particular focus on the need to embed gender equity into the heart of institutional and economic structures.
In her keynote address, Hon. Naisula Lesuuda, Member of Parliament, Samburu West, Kenya, cautioned against engaging in performative actions, which carry the risk of contributing towards 'inclusion fatigue'. Real change she said, needs to be more profound and systematic, beginning with the very language we use to think about leadership and society:
'Beyond existing laws and policies, what are some of the cultural things we need to change in our spaces to give women more room to work and thrive? One of them, which we can all change in our organisations, is something as simple as language. In Parliament, we had to push to change our standing orders from 'chairman' of committees to 'chairperson' – because in their minds, 'chairman' automatically meant a man. As a result, all the committees, especially the powerful ones, were headed by men. So even just the language that we use in our spaces sets a mindset and a stereotype.'
Dr Nkiru Balonwu, founder of the Africa Soft Power Group and lead convener on its flagship summit, said that Africans need to define their own DEI frameworks, authentic to the continent's diverse contexts, and emphasised the ability of African soft power to have a wider impact on the global stage:
'We can actually design the DEI framework that we want for people to follow, as opposed to always following the Western norm. Africa's creative and tech sectors have already proven themselves to be a powerful engine for growth, on both an economic and societal level. African soft power can be a hugely influential force in driving positive change.'
Creative & Innovative Industries Conference
Africa's ability to influence positive change on a global level was a concept that also ran throughout the Creative and Innovative Industries Conference, taking place on the second day of the proceedings. In an agenda packed full of cutting-edge themes around AI, finance tech, creative & corporate funding, and the need to balance growth and stability… infrastructure – in all its forms – emerged as a key focal point.
Philip Ikeazor, Deputy Governor, Financial System Stability, Central Bank of Nigeria (CBN), indicated that regulators are working to support the growth of digital finance, while constantly developing baseline standards that incorporate the latest technologies. 'Infrastructure is what connects capital to innovation, he said. 'Safety and security are paramount - not just from the business side, but from a systemic point of view.'
Aliya Shariff, Senior Director for Africa Catalytic Impact Fund, Mastercard Foundation, highlighted that while much of our conceptualisation of infrastructure often leans towards hardware (roads, buildings, energy, etc.) we must not forget that software is the lifeblood of today's digital world, as well as the human communication that surrounds it:
'We need to think more about 'soft infrastructure in terms of regulatory clarity, data protection laws, and system interoperability.' This also extends to issues surrounding access, digital inclusion, and more level playing fields, explained Sharrif, stating: 'Our businesses aren't inferior, they're just more expensive to operate. Inclusion isn't just access; it's affordability and usability. Even though Africa is leapfrogging into mobile finance, the continent still struggles with smartphone affordability, energy availability, and device taxation policies.'
Leading by example
The summit at large provided a range of high-level perspectives on some of the key issues of the day. There was consideration of the continent's role in the advancement of AI, with input from Google Research Africa's Lorna Omondi and Kojo Boakye - VP of Public Policy, Africa, Middle East and Türkiye, Meta, while Africa's sports and entertainment sectors were presented as underleveraged growth assets.
Chi Ogbuehi, VP of Marketing Technology & Consumer Products, National Football League (NFL), discussed initiatives like the NFL's International Player Pathway, aimed at cultivating talent directly within Africa, noting the shift towards investing in local development ecosystems. Investment in these sectors, as noted by Julio De Souza, Vice President, Venture Capital and Impact Finance, StratLink, requires building "investable, local, and foreigner" opportunities, and leveraging the intersection with technology and other entertainment forms for monetization and fan engagement.
Overall, the 2025 Africa Soft Power Summit outlined a clear direction: that Africa's growth is an ongoing reality, driven by the ingenuity of its populace, the dynamism of its creative and technological sectors, and the increasing influence of its women leaders.
The primary call from business leaders attending the summit was to turn such energy and insights into tangible results on the ground, on both an economic and societal level.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
39 minutes ago
- The Hill
Beijing official overseeing Hong Kong warns of persisting national security threats
HONG KONG (AP) — A top Beijing official overseeing Hong Kong affairs on Saturday warned of persisting threats in the city as a China-imposed national security law approaches its fifth anniversary, while seeking to allay concerns about the law's impact on the financial hub's openness. Speaking at a forum about the law, attended also by the city leader John Lee and other officials, Xia Baolong, the director of China's Hong Kong and Macao Work Office, said various forms of soft resistance continue to emerge in new forms and external forces have never ceased their intervention in Hong Kong. 'Hong Kong has transformed from chaos to order. But just as a tree desires stillness, the wind continues to blow,' Xia said. The Beijing and Hong Kong governments deemed the law necessary to maintain the city's stability following anti-government protests in 2019. Under the law, many leading pro-democracy activists, including Jimmy Lai, founder of the now-defunct Apple Daily newspaper, were prosecuted. Dozens of civil society groups disbanded. This month, authorities have stepped up their crackdown, including charging young activist Joshua Wong, who was already sentenced last year over a subversion case, under the law for the second time and targeting a mobile game app. Last week, China's national security authorities in Hong Kong and the city's police launched their first publicly known joint operation, raiding the homes of six people on suspicion of colluding with foreign forces to endanger national security. Critics say the political changes indicate that the Western-style civil liberties Beijing promised to keep intact when the former British colony returned to Chinese rule in 1997 are shrinking. But Xia said the law only targeted an extremely small number of people who severely endanger national security. He also sought to allay concerns about Hong Kong's openness and international position. He insisted that normal international exchanges do not violate Hong Kong's national security law but rather are protected by it.
Miami Herald
an hour ago
- Miami Herald
Econometer: Should the US ban drug advertising to consumers?
The U.S. is rare among Western nations because it allows pharmaceutical advertising. But a new effort aims to stop it. A bill was introduced in Congress recently that would ban pharmaceutical manufacturers from using direct-to-consumer advertising, from TV to social media, to promote their products. Prescription drug advertising employs a lot of people, directly and indirectly. Billions are spent on advertising each year, employing advertising workers, and 24.4% of ad minutes were for prescription drugs across evening news programs on ABC, CBS, CNN, Fox News, MSNBC and NBC this year through May, according to data from iSpot analyzed by The Wall Street Journal. Proponents of the bill say advertising drives up the cost of prescription goods. Pharmaceutical trade groups have said advertisements serve public health by increasing disease awareness and educating consumers about treatment options. Question:Should the U.S. ban drug advertising to consumers? Economists Alan Gin, University of San Diego YES: Advertising is supposed to give consumers more information about products, but are consumers really in a position to make an informed decision about pharmaceuticals? Those decisions are best left to physicians, who probably have more knowledge about the effectiveness of medications. Consumers can be swayed by slick and repetitive ads into wanting products that might not be the best for them. The money spent on the ads will add to the already high price of the drugs. James Hamilton, UC San Diego NO: Proponents of a ban argue that ads cause people to request unnecessary drugs. But advertisements helped several of my friends learn about options that they didn't know were available. I'm also concerned any time the government dictates what companies are allowed to talk about. It's appropriate to ensure ads do not make inaccurate claims. And doctors should always say no if patients request a prescription that the doctor does not believe is going to help them. Caroline Freund, UC San Diego School of Global Policy and Strategy YES: Advertising specific drugs leads to overprescribing, higher drug and insurance prices, and creates bad incentives, like promoting the most profitable drugs. Because insurance limits consumer costs, more prescription drugs are purchased than needed or used. If the goal is to share important information, industry groups can promote a range of treatments for a condition, leaving discussions of individual products to medical professionals. Drugs also carry risks that are not easily captured in 30 seconds. Kelly Cunningham, San Diego Institute for Economic Research NO: Firms do not advertise to raise costs but engage in marketing to inform the public (especially doctors writing prescriptions) of the drug's usefulness. Without marketing, firms would be unable to get information out necessary to make a drug salable in the first place. The drug's value is decided by the marketplace with consumers driving the entire process. Value of advertising is derived from the value consumers place on the drug, not the other way around. Norm Miller, University of San Diego NO: While most physicians try to keep up on the latest drug research, some do not, thus the need for public information about new drugs. What should be mandatory in ads are their efficacy, side effects and potential for addiction, using FDA verified stats. Lies and exaggerations should be illegal. It should also be illegal for drug manufacturers to incentivize or pay doctors for prescribing any drug, and physicians that take such gifts should lose their license. Ray Major, economist YES: Every ad starts with or ends with "ask your doctor if this drug is right for you." Prescription drug advertisement targets consumers hoping they ask their doctor for a specific brand of drug. Consumers are not qualified to self diagnose symptoms and prescribe drugs to themselves based on information from a commercial. Doctors should be prescribing drugs based on a patients' needs and not influenced by patients who have seen an ad for a prescription drug. David Ely, San Diego State University NO: Commercial speech by pharmaceutical companies that is truthful and informative should be protected. A ban on drug advertising goes too far. A better option is enhanced regulation by the FDA and FTC to ensure that the risks and effectiveness of prescription drugs are accurately communicated in advertising to the public. Under a ban, resources would be shifted to increased promotional efforts targeting health care providers so the cost of prescription goods may not decline. Executives Gary London, London Moeder Advisors NO: I am not a big fan of drug advertisements, but unlike cigarette ads, which clearly promoted sickness for generations, at least drugs are lifesaving. The government should not get involved. However, I have never fully understood why pharmaceutical companies promote directly to patients rather than physicians. They complicate medical care. Be that as it may, these advertisements certainly prop up the cable channels, who need the revenue. Bob Rauch, R.A. Rauch & Associates YES: The U.S. and New Zealand are the only countries that allow pharmaceutical companies to advertise directly to consumers. Drug ads often downplay the risks, leading to uninformed decisions. Ads can push consumers toward brand-name drugs, even when cheaper alternatives exist. Also, patients may request unnecessary medications, pressuring doctors to prescribe them. Sure, ads can educate, lead to earlier diagnosis, and boost the economy! But let's limit ads during the first few years of release. Phil Blair, Manpower NO: They are a product like any other. With artificial intelligence, clients and patients can educate themselves on various options just like they do with other products. Of course, they should heed their doctors' advice. Austin Neudecker, Weave Growth YES: Drugmakers spent $10 billion on direct-to-consumer ads last year. These costs are ultimately reflected in the world's highest per-capita health care bill, with relatively poor health outcomes. Slick spots encourage viewers to "ask your doctor" for brands even when cheaper generics accomplish the same goal. Treatment decisions should be based on clinical evidence, not marketing budgets. Pharma could shift a fraction of this outreach to physician education so that patients will still learn about therapies from an informed source. Chris Van Gorder, Scripps Health YES: Absolutely. The cost of pharmaceuticals has become prohibitive to patients and providers like hospitals, and the huge cost of advertising is wrapped into those costs. While we want informed patients, pharmaceutical education should be handled by patients' physicians, not a jingle on TV. Advertising also can be misleading and increase the cost of drugs to taxpayers - which is why many countries prohibit advertising. Jamie Moraga, Franklin Revere NO: While I don't enjoy watching the litany of drug advertisements consistently shown on family programming, I don't support a blanket ban. Instead, drug advertising should follow the model currently allowed to cigarette advertising: prohibit ads on TV and radio but allow other forms of advertising with appropriate limitations and regulations. While raising awareness of available treatments can be beneficial, the current barrage of drug advertising is excessive and likely leads to over prescription and increased health care costs. Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Beijing official overseeing Hong Kong warns of persisting national security threats
HONG KONG (AP) — A top Beijing official overseeing Hong Kong affairs on Saturday warned of persisting threats in the city as a China-imposed national security law approaches its fifth anniversary, while seeking to allay concerns about the law's impact on the financial hub's openness. Speaking at a forum about the law, attended also by the city leader John Lee and other officials. Xia Baolong, the director of China's Hong Kong and Macao Work Office, said various forms of soft resistance continue to emerge in new forms and external forces have never ceased their intervention in Hong Kong. 'Hong Kong has transformed from chaos to order. But just as a tree desires stillness, the wind continues to blow," Xia said. The Beijing and Hong Kong governments deemed the law necessary to maintain the city's stability following anti-government protests in 2019. Under the law, many leading pro-democracy activists, including Jimmy Lai, founder of the now-defunct Apple Daily newspaper, were prosecuted. Dozens of civil society groups disbanded. This month, authorities have stepped up their crackdown, including charging young activist Joshua Wong, who was already sentenced last year over a subversion case, under the law for the second time and targeting a mobile game app. Last week, China's national security authorities in Hong Kong and the city's police launched their first publicly known joint operation, raiding the homes of six people on suspicion of colluding with foreign forces to endanger national security. Critics say the political changes indicate that the Western-style civil liberties Beijing promised to keep intact when the former British colony returned to Chinese rule in 1997 are shrinking. But Xia said the law only targeted an extremely small number of people who severely endanger national security. He also sought to allay concerns about Hong Kong's openness and international position.
